Form 4 for IDXX Idexx Laboratories
Accepted 2023-02-16 00:00:00 ET · period of report 2023-02-14 · accession 0001567619-23-003221 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-02-16 | 2023-02-14 | IDXX | POLEWACZYK JAMES F | EVP | M - OptEx | $0.00 | +834 | 16.6K | +5% | $0 |
| D | 2023-02-16 | 2023-02-14 | IDXX | POLEWACZYK JAMES F | EVP | F - Tax | $503.65 | +252 | 16.0K | +2% | +$126.9K |
| DM | 2023-02-16 | 2023-02-14 | IDXX | POLEWACZYK JAMES F | EVP | M - OptEx | — | -834 | 2,155 | -28% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-14 | M | A | 216 | $0.00 | 15,898.28 | D | — | — | |
| 2 | Common | Common Stock | 2023-02-14 | M | A | 204 | $0.00 | 16,263.28 | D | — | — | |
| 3 | Common | Common Stock | 2023-02-14 | F | A | 252 | $503.65 | 16,011.28 | D | — | — | |
| 4 | Common | Common Stock | 2023-02-14 | M | A | 127 | $0.00 | 15,682.28 | D | — | — | |
| 5 | Common | Common Stock | 2023-02-14 | M | A | 126 | $0.00 | 15,555.28 | D | — | — | (F7) Adjusted to include 1 additional share of Issuer common stock due to a scrivener's error. |
| 6 | Common | Common Stock | 2023-02-14 | M | A | 161 | $0.00 | 16,605.28 | D | — | — | |
| 7 | Derivative | Restricted Stock Unit | 2023-02-14 | M | D | 161 | — | 2,359 | D | — · — to — | 161 Common Stock | (F6) Not applicable. (F4) Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022. |
| 8 | Derivative | Restricted Stock Unit | 2023-02-14 | M | D | 216 | — | 2,520 | D | — · — to — | 216 Common Stock | (F6) Not applicable. (F3) Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2021. |
| 9 | Derivative | Restricted Stock Unit | 2023-02-14 | M | D | 127 | — | 2,736 | D | — · — to — | 127 Common Stock | (F6) Not applicable. (F2) Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020. |
| 10 | Derivative | Restricted Stock Unit | 2023-02-14 | M | D | 126 | — | 2,863 | D | — · — to — | 126 Common Stock | (F6) Not applicable. (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning February 14, 2019. |
| 11 | Derivative | Restricted Stock Unit | 2023-02-14 | M | D | 204 | — | 2,155 | D | — · — to — | 204 Common Stock | (F6) Not applicable. (F5) Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023. |